thirty-three patients with advanced carcinoid tumors , islet cell carcinomas , or medullary carcinomas of the thyroid were entered into a phase ii trial combining streptozotocin ( stz ) and adriamycin .
C1328479
islet cell carcinomas
C0038432
streptozotocin